Most cells do metabolic somersaults to survive under stressful a condition – which is to say, they enlist the most expedient biochemical pathways to produce essential molecules in order to survive. By comparison, cancer cells perform high-wire cartwheels to recruit alternative pathways to thwart cancer drugs. As cancer cells do... Read more
What once was called “personalized medicine” at Penn used to be practiced primarily by individuals or small groups of researchers and clinicians drawn to its possibilities. But as the cover story in the Summer 2016 issue of Penn Medicine demonstrates, the ability to harness vast amounts of information and apply... Read more
Colon cancer is the most common of gastrointestinal (GI) cancers and the third leading cause of cancer-related deaths in in the United States, but it’s also largely preventable and often curable with early detection. Thanks to an increase in education and awareness around the disease, greater numbers of Americans are... Read more
Days after President Obama announced the “moonshot” to find a cancer cure during his State of the Union, Vice President Biden visited Penn’s Abramson Cancer Center to kick off the national effort he said aims to “accelerate the progress already underway” – much of which is happening right here. "You're... Read more
In a few weeks, top minds in the city and state will gather to discuss one of the hottest cancer topics in healthcare: precision medicine. It’s a term many have heard, seen on a billboard, or even experienced, but what does the omnipresent buzzword really mean today—and for tomorrow? For... Read more
We put together a slideshow of photographs to give a glimpse inside the Abramson Cancer Center’s (ACC) first “Philly Fights Cancer” fundraiser, but perhaps the best picture of the night was snapped Ellen-Degeneres-at-the-Oscars-style on an iPhone during the program. “Everyone get ready," said Tracy Davidson, NBC10 anchor and emcee for... Read more
A few weeks ago, news broke that the founder of Turing Pharmaceuticals, Martin Shkreli, bought the 62-year-old drug daraprim, only to turn around and up the cost by 5,000 percent. The move by Shkreli, who said the revenue would fund research to develop better treatments for toxoplasmosis, the parasitic infection... Read more
Lois Hahn couldn’t have been happier on Tuesday. The 71-year-old wife and grandmother was back at Penn’s Abramson Cancer Center, with her son and husband by her side, for a follow-up visit with her medical oncologist, Alexander Perl, MD, an assistant professor of Hematology/Oncology in the ACC. She’s feeling and... Read more
I read a very witty and apt tweet at this week’s American Society of Clinical Oncology (ASCO) annual meeting—the medical conference attended by over 30,000 oncologists and others in the field from all over the world: “Immunotherapy is like the hashtag—it’s here to stay.” The pithy 100 or so characters—replete... Read more
Late last month Penn Medicine observed the fortieth Medical Laboratory Professionals Week, a time to recognize the hard work and dedication of the 600-plus lab professionals in more than 30 laboratories across the health system. Read more
Penn Medicine has been at the forefront of rare disease research for decades, and these efforts – as well as many of its other research and clinical milestones -- are being honored this year as part of the Perelman School of Medicine’s 250th anniversary celebration. Read more
Greenberg Cancer Discovery blog post imageMany families are acutely aware that BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. But recently a team including researchers at Penn Medicine discovered another risk it can pose in cancer patients when both parents carry the mutation. Read more
Before we ring in the New Year, the Penn Medicine department of Communications is taking a look back at 2014, a year filled with more breakthroughs in medical research, growth at the Penn Medicine campus, and philanthropic support. This year, we took a different approach and put together a year...
With such astounding shortfalls in funding for biomedical research, Penn Medicine, a key stakeholder of the new Penn Center for Innovation (PCI), is looking for fresh ways to fund research and partner with the private sector. The PCI consolidates and unifies the enterprise previously known as the Penn Center for Technology Transfer with other campus entities charged with commercializing Penn research and Development into license agreements, sponsored research agreements, startup companies and other collaborative relationships. Read more
Acute myeloid leukemia (AML) is one of those cancers so genetically complex, with its many chromosomal abnormalities and mutations, that it has been hard for doctors to find clinically meaningful information to sort out this diversity. So when three gene sequencing studies from Penn Medicine show patterns that may help... Read more
Perelman School genetics professor Maja Bucan, PhD, told me of her deep appreciation for the work going on at the clinic: “From my first visit to the clinic [Clinic for Special Children], I knew I wanted to be part of their team as a collaborator.” Read more
Late last month Penn Med observed Medical Laboratory Professionals Week, a time to celebrate the hard work and dedication of the 600-plus lab professionals in more than 30 laboratories across the health system.
The first annual Million Dollar Bike Ride is finally here. On Saturday, May 3, 2014, close to 500 riders and many other volunteers and family members will gather at Highline Park on Penn’s campus to raise funds for and awareness about rare diseases. Read more
The new Penn Center for Wound Healing and Reconstruction – to treat people dealing with unrelenting wounds – aims to simplify the process by bringing a cadre of specialists together, centering around patient needs.
Rare Disease Day is an annual event to raise awareness with the general public and decision-makers about rare diseases and their impact on patients’ lives. Read more